Skip to main content

trade with estonia

BIO International Convention 2024: Estonian Biotech Pioneers Pushing Boundaries

Come see us at San Diego Convention Center stand no 3541!

When?
03 Jun - 06 Jun 2024
Where?
San Diego Convention Center, California

As the world’s most advanced digital nation, Estonia offers fertile ground for innovation across the biotech industry.

Co-funded by the European Union + Investing in your future (ENG)

Living up to this law of nature, the tiny country of Estonia continues to punch above its weight. The country’s uniquely entrepreneurial environment, solid scientific and research foundation, and strongly interconnected scientific community provide the perfect backdrop for breakthroughs ranging from Europe’s first CE-marked cancer polygenic risk score tests to viral transport solution technology that enables direct real-time PCR without the need of any nucleic acid extraction or purification methods.

Meet the leading-edge biotech companies participating at BIO International Convention 2024 and pushing boundaries with their in-depth knowledge and constant drive to improve the world through science.

 

 

Gearbox Biosciences

Gearbox Biosciences has developed a novel antibiotic-free protein production technology for E. coli. No antibiotics in a bioreactor means less regulatory concern and easier waste management.
  • About
  • Contact
  • Gallery
  • Video

About

Gearbox Biosciences provides a novel antibiotic-free protein production technology in E. coli. Our strains do not require antibiotics or small-molecule inducers like IPTG, but produce proteins at high levels. This will  reduce regulatory scrutiny and help the protein producers to cut costs – waste management is easier and there is no need to worry about antibiotic resistance gene contamination.

Gallery

Video

Book a meeting

Vectiopep

Vectiopep develops new type of cancer immunotherapy with its unique mRNA delivery technology.
  • About
  • Contact
  • Gallery

About

Cancer immunotherapy activates our immune system against tumor. This can be executed by sending an mRNA message to the immune cells. Up to now, the key limitation has been the transport of therapeutic mRNA into the patients.   Vectiopep has developed a unique technology that achieves unprecedented selectivity in transporting mRNA to the patient’s immune cells.   We will out-license our technology to the pharmaceutical companies to be used as a component in an oncology drug.

Gallery

Book a meeting

Icosagen Cell Factory

We translate your ideas into proteins
  • About
  • Contact
  • Gallery

About

Icosagen, a leading CRDMO for the biopharmaceutical, biotechnology, and diagnostic industries, was founded in 1999. In 2022, we worked with 100+ companies, producing 3000+ proteins. Our seamless services include early clinical candidate development and stable CHO cell line development for 50L to 1000L GMP production runs. Clients trust us for custom-tailored solutions in every stage of drug development, from complicated protein discovery to recombinant production.

Gallery

Book a meeting

Chemestmed

We are on the mission to develop disruptive therapeutics for a variety of neurodegenerative and neuropsychiatric diseases, cancer and viral infections
  • About
  • Contact

About

Chemestmed Ltd. has developed proprietary technologies and drug candidates based on the therapeutically targeted regulation of the RNA 6-methyladenosine (m6A) level in cells. Those include: (a) Activators of the RNA m6A methylation and their application in the case of neurodegenerative, neuropsychiatric and metabolic disorders, (b) Inhibitors of RNA m6A methyltransferase METTL16, RNA m6A demethylase AlkBH5 and RNA m6A demethylase FTO against cancer and neurodegeration (AlkBH5, FTO).

Contact

Mihkel Märtson

CEO

+372 503 4500

[email protected]
Book a meeting

Gelatex Technologies

Enabling the use of nanofibrous materials in biotech applications from cell culture and tissue engineering to drug delivery and wound care.
  • About
  • Contact
  • Gallery
  • Video

About

Employing their patented halospinning technology, Gelatex is a pioneer in the high-speed production of nanofibrous materials. Halospinning is the world’s fastest and most efficient nanofiber technology reducing production costs up to 90%. Gelatex’s nanofibrous scaffolds replicate the natural cell growth environment advancing 3D cell culture and tissue engineering. The versatility of nanofibers extends to diverse applications, including controlled drug delivery, wound care, and regenerative medicine.

Gallery

Video

Book a meeting

Bioatlas

Already a lot US schoolkids make their first steps in biotechnology using Bioatlas´ innovative products
  • About
  • Contact

About

Bioatlas has been focusing on PCR and agarose gel electrophoresis for 15 years already. Still, our main aim is to revolutionize agarose gel preparation around the world with the help of our partners. We are looking for distribution partners, OEM resellers and scientific partners to meet our goals. Currently our main goal is to introduce safe DNA stains to every lab around the world. Our patented tablet format makes it even more appealing.

Book a meeting

BIO International Convention 2024: Estonian Biotech Pioneers Pushing Boundaries

03 Jun 2024

San Diego Convention Center, California

Request sourcing help